Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5484159 | 0.94 | ABCB1 (0.42) | ABCB1LMNACYP2C19HIF1ATDP1 | |
| SCHEMBL28880448 | 0.86 | LMNA (0.36) | ABCB1LMNACYP2C19HIF1ATDP1 | |
| SCHEMBL11387672 | 0.85 | ABCB1 (0.38) | ABCB1LMNACYP2C19HIF1ATDP1 | |
| SCHEMBL8338637 | 0.84 | ABCB1 (0.30) | ABCB1POLBMAPK1 | |
| SCHEMBL9009211 | 0.84 | ABCB1 (0.38) | ABCB1TDP1POLBMAPK1AR | |
| SCHEMBL7986029 | 0.84 | LMNA (0.35) | ABCB1LMNACYP2C19HIF1ATDP1 | |
| SCHEMBL8905997 | 0.83 | LMNA (0.38) | ABCB1LMNACYP2C19HIF1ATDP1 | |
| SCHEMBL8377994 | 0.82 | LMNA (0.38) | ABCB1LMNACYP2C19HIF1ATDP1 | |
| SCHEMBL1359798 | 0.82 | LMNA (0.38) | ABCB1LMNACYP2C19HIF1ATDP1 | |
| SCHEMBL28880451 | 0.80 | LMNA (0.43) | ABCB1LMNACYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0700377-B1 | PURIFICATION OF 1,1,2-TRICHLOROETHANE | MALLINCKRODT MEDICAL INC (US) | 1999-03-31 | — | — | EP | claimed |
| EP-0598751-B1 | SYNTHESIS OF IOVERSOL USING CHLOROACETYL CHLORIDE | MALLINCKRODT MEDICAL INC (US) | 1999-03-24 | — | — | EP | claimed |
| EP-0640067-B1 | IMPROVED SYNTHESIS OF IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 1997-03-12 | — | — | EP | claimed |
| EP-0640067-A4 | IMPROVED SYNTHESIS OF IOVERSOL. | MALLINCKRODT MEDICAL INC (US) | 1995-05-31 | — | — | EP | claimed |
| EP-0640067-A1 | IMPROVED SYNTHESIS OF IOVERSOL. | MALLINCKRODT MEDICAL INC (US) | 1995-03-01 | — | — | EP | claimed |
| WO-1993023365-A1 | IMPROVED SYNTHESIS OF IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1993-11-25 | — | — | WO | claimed |
| EP-0513063-A1 | PROCESS FOR PRODUCTION OF IOVERSOL. | MALLINCKRODT INC (US) | 1992-11-19 | — | — | EP | claimed |
| US-4997983-A | Process for production of ioversol | MALLINCKRODT, INC. (US) | 1991-03-05 | — | — | US | claimed |
| EP-0839056-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-09-13 | — | — | EP | disclosed |
| EP-0886634-A4 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL INC (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-0700377-B1 | PURIFICATION OF 1,1,2-TRICHLOROETHANE | MALLINCKRODT MEDICAL INC (US) | 1999-03-31 | — | — | EP | disclosed |
| EP-0886634-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-12-30 | — | — | EP | disclosed |
| EP-0839056-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1998-05-06 | — | — | EP | disclosed |
| WO-1997027172-A1 | PROCESS FOR PRODUCING IOVERSOL | MALLINCKRODT MEDICAL, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0513063-B1 | PROCESS FOR PRODUCTION OF IOVERSOL | MALLINCKRODT INC (US) | 1995-05-17 | — | — | EP | disclosed |
| WO-1994027956-A1 | PURIFICATION OF 1,1,2-TRICHLOROETHANE | MALLINCKRODT MEDICAL, INC. (US) | 1994-12-08 | — | — | WO | disclosed |
| EP-0516050-A2 | Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures | BRACCO INTERNATIONAL B.V. (NL) | 1992-12-02 | — | — | EP | disclosed |
| EP-0513063-A1 | PROCESS FOR PRODUCTION OF IOVERSOL. | MALLINCKRODT INC (US) | 1992-11-19 | — | — | EP | disclosed |
| WO-1991011431-A1 | PROCESS FOR PRODUCTION OF IOVERSOL | MALLINCKRODT, INC. (US) | 1991-08-08 | — | — | WO | disclosed |
| US-4997983-A | Process for production of ioversol | MALLINCKRODT, INC. (US) | 1991-03-05 | — | — | US | disclosed |